Vimarsana
Biggest News Aggregation in the World

Page 31 - Aptar Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Aptar Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Aptar Pharma Today - Breaking & Trending Today

Aptar Pharma Acquires Metaphase Design Group Inc - Vimarsana News

Aptar Pharma Acquires Metaphase Design Group Inc

Aptar Pharma, a global leader in drug delivery and active material science solutions and services, today announced that it has acquired Metaphase...

Aptar Pharma Expands Human Factors Capabilities Through Acquisition of Metaphase Design Group, Inc. - Vimarsana News

Aptar Pharma Expands Human Factors Capabilities Through Acquisition of Metaphase Design Group, Inc.

Aptar Pharma Expands Human Factors Capabilities Through Acquisition of Metaphase Design Group, Inc.This expanded capability enables Aptar Pharma to continue to put the patient at theforefront of designCrystal Lake, Illinois, September 1, 2022 - Aptar Pharma, a global leader in drug delivery and active material scien...

Aptar Pharma Acquires Metaphase Design Group Inc - Vimarsana News

Aptar Pharma Acquires Metaphase Design Group Inc

Aptar Pharma, a global leader in drug delivery and active material science solutions and services, today announced that it has acquired Metaphase...

Pharmaxis lands US$5 million deal with global drug delivery specialist - Vimarsana News

Pharmaxis lands US$5 million deal with global drug delivery specialist

Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) CEO Gary Phillips details a multi-million-dollar deal the company's just struck with global drug delivery specialist...

Aptar Pharma Acquires Worldwide License for Orbital™ Dry Powder Inhaler From: Aptar Pharma - Vimarsana News

Aptar Pharma Acquires Worldwide License for Orbital™ Dry Powder Inhaler From: Aptar Pharma

The license will help Aptar Pharma meet the growing global demand for safe and convenient administration of high-dose treatments to the lungs.